Sales Slump Hikes Losses for BoMed Manufacturing

Losses at BoMed Medical Manufacturing Ltd. widened during its fourth quarter and fiscal year, ended Nov. 30, the company reported last week.

In the fourth quarter, the Irvine-based company lost $275,595, compared to a loss of $113,645 in the same quarter of the previous year. BoMed, which develops and markets instruments for monitoring the heart and circulatory system, had revenues of $90,120 for the quarter, down 8.7% from $98,730 from the year-ago quarter.

For its 1984 fiscal year, the company lost $1.3 million, compared to $382,705 for fiscal year 1983.

Karen Carpenter, BoMed’s controller, attributed the losses to lower than expected sales and product delays during clinical testing stages.